Evidence map›Paper›PMID 36293440›Full record

ReviewInternational journal of molecular sciences2022

The Contribution of

Jhemerson Paes, George A V Silva, Andréa M Tarragô, Lucivana P de Souza Mourão

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Portal Vein Thrombosis: State-of-the-Art Review.Journal of clinical medicine · 2024
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jhemerson PaesPrograma de Pós-Graduação em Ciências Aplicadas à Hematologia, Universidade do Estado do Amazonas (UEA), Manaus 69850-000, AM, Brazil.ORCID 0000-0001-5639-7041
George A V SilvaPrograma de Pós-Graduação em Ciências Aplicadas à Hematologia, Universidade do Estado do Amazonas (UEA), Manaus 69850-000, AM, Brazil.ORCID 0000-0001-9803-1996
Andréa M TarragôPrograma de Pós-Graduação em Ciências Aplicadas à Hematologia, Universidade do Estado do Amazonas (UEA), Manaus 69850-000, AM, Brazil.ORCID 0000-0003-3125-580X
Lucivana P de Souza MourãoPrograma de Pós-Graduação em Ciências Aplicadas à Hematologia, Universidade do Estado do Amazonas (UEA), Manaus 69850-000, AM, Brazil.ORCID 0000-0003-3121-6667
Universidade do Estado do Amazonas · BR

Funding

Fundação de Amparo à Pesquisa do Estado do Amazonas POSGRAD Program - #005/2022Fundação de Amparo à Pesquisa do Estado do Amazonas Pró-Estado Program - #002/2008, #007/2018 and #005/2019
6 · The paper itself

Abstract

Haplotype 46/1 (GGCC) consists of a set of genetic variations distributed along chromosome 9p.24.1, which extend from the Janus Kinase 2 gene to Insulin like

Indexed as

InsulinsMyeloproliferative DisordersNeoplasmsDisease SusceptibilityHaplotypesHumansJanus Kinase 2MutationInsulinsJAK2 protein, humanJanus Kinase 2haplotypeJAK2 germline haplotypemolecular pathogenesismyeloid neoplasmssingle nucleotide polymorphisms

Identifiers

PMID36293440
PMCPMC9604447
OpenAlexW4306925867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.